Abstract
The aim of this chapter is to provide a critical overview of cost-effectiveness studies of antipsychotics in the treatment of psychotic disorders. Relevant studies were briefly reviewed and analyzed according to perspective, funding sources, outcomes, comparators, and time horizon. Differences in the costeffectiveness of older, first-generation antipsychotics and the newer secondgeneration drugs are still a matter of debate. Several methodological issues limit the generalization of cost-effectiveness studies across countries.
Cite
CITATION STYLE
Kayo, M., & Razzouk, D. (2017). Cost-effectiveness of antipsychotics in the treatment of schizophrenia disorders. In Mental Health Economics: The Costs and Benefits of Psychiatric Care (pp. 313–322). Springer International Publishing. https://doi.org/10.1007/978-3-319-55266-8_20
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
